LFB's vote of Confidence
Shigamabs is basically a novel technology. Does it work? Will it work?
Seems like the world expert on monoclonal antibodies think that these dual antibodies that is shigamabs will work.
Pretty strong vote of confidence.
Pretty darn lucrative deal for a micro-biotech (150M)
An institutional believer will soon enter and take a significant position for the future.